A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors
LEAN3
A Randomized Controlled Trial, Using a Mail and Video-based Weight Loss Program for Overweight or Obese Stage I-IIIC Breast Cancer Survivors.
1 other identifier
interventional
205
1 country
1
Brief Summary
Proposed is a 6-month randomized controlled trial, in 200 overweight or obese Stage I-IIIC breast cancer survivors examining 6-month changes in: 1) body weight, 2) diet, 3) physical activity, and 4)quality of life in women randomized to receive the modified LEAN intervention compared to women randomized to wait-list control (i.e., the wait-list control will receive the modified LEAN intervention after completing the 6-month study).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2016
CompletedFirst Posted
Study publicly available on registry
February 15, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedJune 29, 2018
June 1, 2018
2.1 years
February 10, 2016
June 28, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Body weight (kg)
A standard digital scale will be mailed to each participant along with the baseline packet to allow consistent measurement of weight by participants. Participants will weigh themselves. Body weight will be collected in kilograms (kg).
6 Months
Secondary Outcomes (13)
Body weight (kg)
Baseline
Body weight (kg)
12 Months
Quality of Life (QOL)
Baseline
Quality of Life (QOL)
6 months
Dietary Intake
Baseline
- +8 more secondary outcomes
Study Arms (2)
LEAN
EXPERIMENTALParticipants randomized to the weight loss program will initially receive the LEAN book, as well as a CD and flash drive with the LEAN videos (and internet link), a pedometer and the Log Book for recording their food intake and physical activity. Written instructions in the LEAN book will include recording daily diet and exercise in the logs. At the end of the study, participants will return, via a stamped addressed envelope, the logs to the study office so compliance can be assessed.
Waitlist Control
NO INTERVENTIONParticipants randomized to the waitlist control study arm will be mailed the six-month questionnaires, which will include reporting of weight. On return of the 6-month questionnaires each woman will be provided with the entire weight loss program packet.
Interventions
The intervention focuses on achieving long lasting lifestyle changes to achieve weight loss and maintenance. Women randomized to the weight loss program will receive the LEAN book, as well as a CD and flash drive with the LEAN videos (and internet link), a pedometer and the Log Book for recording their food intake and physical activity.
Eligibility Criteria
You may qualify if:
- Overweight individuals (BMI \>= 25.0 kg/m2)
- Breast cancer survivors who have completed chemotherapy and/or radiation therapy
- Stage 0-III
- The ability to be physically able to exercise (e.g. walk at a moderate pace)
- Agree to random assignment to either group
- Give informed consent to participate in all study activities
- Accessible by telephone
- Able read and communicate in English
You may not qualify if:
- Pregnant or intending to become pregnant in the next year
- Recent (past 6 months) stroke or myocardial infarction
- Severe uncontrolled mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale University
New Haven, Connecticut, 06511, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yale School of Medicine Irwin, Ph.D.
MEPH Chronic Diseases, Yale School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2016
First Posted
February 15, 2016
Study Start
March 1, 2016
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
June 29, 2018
Record last verified: 2018-06